(Reuters) - U.S. drugmaker Bristol-Myers Squibb Co on Tuesday said Chief Operating Officer Giovanni Caforio will replace Lamberto Andreotti as chief executive on May 5, as the company again tapped a long-time insider to lead it. The 50-year-old Caforio, who has a medical background and led the company's global oncology operations, will take over Bristol-Myers at a time when it is riding high behind its new high-profile cancer drugs that help the immune system fight the disease. Andreotti, 64, who has been CEO since May 2010 after a long career with the company, will become executive chairman of the board on May 5 and continue as chairman after his Aug. 3 retirement, the company said. Caforio has been on the Bristol-Myers board since last year. via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment